TickerFactsScreenerDevelopers

Ultragenyx Pharmaceutical Inc. (RARE) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2011: -$7.96M2012: -$27.05M2013: -$74.82M2014: $184.94M2015: $531.09M2016: $473.97M2017: $383.45M2018: $608.91M2019: $653.76M2020: $1.15B2021: $922.56M2022: $352.00M2023: $275.00M2024: $255.00M2025: -$80.00M-$80.00M
2011Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025-$80.00M-131.4%
2024$255.00M-7.3%
2023$275.00M-21.9%
2022$352.00M-61.8%
2021$922.56M-20.1%
2020$1.15B+76.6%
2019$653.76M+7.4%
2018$608.91M+58.8%
2017$383.45M-19.1%
2016$473.97M-10.8%
2015$531.09M+187.2%
2014$184.94M+347.2%
2013-$74.82M-176.6%
2012-$27.05M-239.7%
2011-$7.96M—